Michael Gelband’s Acacia Research ACTG Stock Holding History

Michael Gelband’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-17,501	Closed	-$116K	–	2278
2021 Q1	$116K	Buy	+17,501	New	+$110K	﹤0.01%	1960

Other funds holding ACTG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

FAM

Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's ACTG Position: Q2 2021 in Review

Michael Gelband sold out of Acacia Research (ACTG) in Q2 2021, closing a stake of 17,501 shares — an estimated $116K sold.

Michael Gelband first reported a position in ACTG in Q1 2021 and held it in 1 quarter. The position peaked at $116K in Q1 2021. 96 funds tracked by Wall St. Rank hold ACTG as of Q2 2021.

Michael Gelband reported no remaining Acacia Research position as of Q2 2021 after selling out during the quarter.
Michael Gelband sold 17,501 Acacia Research shares in Q2 2021, an estimated $116K.
Michael Gelband first reported a position in Acacia Research in Q1 2021 and held it in 1 quarter.
Michael Gelband's Acacia Research position peaked at $116K in Q1 2021.
96 funds tracked by Wall St. Rank held Acacia Research as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.